Skip to main content
NUS logo

NUS · Nu Skin Enterprises, Inc.

Track NUS — free
$3.77 -0.10 (-2.58%) At close · Nov 19
Market Cap
$183.52M
Shares
48.68M
Volume · Nov 19 797.34K Avg daily vol (3M) 526.12K

Price & Indicators

 

Key stats

Close
$3.77
Open
$3.87
Day range
$3.76–3.87
52-week closing range
$3.77–11.54
Average volume, 30 days
543K
Short interest
4.5M · 9.2% of shares · 11.3 days
Short volume, last session
74%
Last earnings
Nov 5, 2026
Latest filing
10-Q · Nov 6
Price history
Jan 2020 to Nov 2026

Up next

Feb 11, 2027 Est · unconfirmed · in 12 wks

Latest documents

2026
Nov 6
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Revenue falls 14.6%, nine-month loss reaches $(248.7) million

Nu Skin reported third-quarter revenue down 14.6% to $311.0 million and a nine-month net loss of $(248.7) million, compared with $145.7 million in the prior-year period.

Revenue $311.01M ▼ 14.6% Net loss $742K Diluted EPS -$0.02
Read from the MD&A section
3 source passages
Revenue for the three-month period ended September 30, 2026 decreased 14.6% to $311.0 million, compared to $364.2 million in the prior-year period, and revenue for the nine-month period ended September 30, 2026 decreased 14.6% to $951.7 million, compared to $1,114.8 million in the prior-year period. As a result of the foregoing factors, net income (loss) for the first nine months of 2026 was $(248.7) million, compared to $145.7 million for the first nine months of 2025. The following table provides information concerning the number of Customers, Paid Affiliates and Sales Leaders in our core Nu Skin business for the three-month periods ended September 30, 2026 and 2025. Open the document at this passage
Nov 5
Earnings call
Revenue $311 million; full-year outlook $1.26 to $1.29 billion

Nu Skin Enterprises reported Q3 revenue of $311 million and adjusted EPS of $0.10, within guidance. Full-year revenue is expected at $1.26 to $1.29 billion, with adjusted EPS of $0.55 to $0.65.

4 source passages
Welcome to the Q3 Nu Skin Enterprises Earnings Conference Call. We delivered revenue of $311 million and adjusted EPS of $0.10, both within our guidance range. For the full year, we now expect revenue of $1.26 to $1.29 billion, including an anticipated foreign currency headwind of approximately 1%. On an adjusted basis, we expect annual earnings per share of $0.55 to $0.65, excluding these non-cash items, certain other year-to-date charges, and anticipated fourth-quarter organizational transition costs. Open the document at this passage
Nov 5
Current report 8-K
Third-quarter revenue falls to $311.0 million

Nu Skin Enterprises Inc. reported third-quarter revenue of $311.0 million versus $364.2 million and EPS of $(0.02), or $0.10 excluding certain charges. It projects 2026 revenue of $1.26 to $1.29 billion and adjusted EPS of $0.55 to $0.65.

Financial results
4 source passages
Nu Skin Enterprises Inc. (NYSE: NUS) today announced third quarter revenue within its guidance range. Revenue | $311.0 million compared to $364.2 million EPS | $(0.02) or $0.10 excluding certain charges compared to $0.34 “For 2026, we project revenue of $1.26 billion to $1.29 billion and earnings per share of $(5.08) to $(4.98) with adjusted EPS of $0.55 to $0.65,” Open the document at this passage
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.32B
Trailing 12 months
Net income (TTM)
−$234.21M
Trailing 12 months
Revenue growth YoY
-14.6%
Year over year
Operating margin
-2.0%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-14.3%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$37.09M
Latest balance sheet
Dividend yield
6.4%
Trailing 12 months
Shares change YoY
-3.2%
Year over year · fewer shares
Price change (1Y)
-60.4%
Trailing year
Short interest
9.2%
Latest settlement · 11.3 days to cover
View all 125 metrics

AI Brief

Q3 FY26 earnings call · Nov 5, 2026
Q3 FY26

TL;DR. Q3 was weak overall: revenue declined 14.6%, gross and adjusted operating margins contracted, customer and sales metrics fell, and full-year guidance calls for a reported loss. Positives included strong RISE growth, improved PRISM conversion and LifePack sales, anticipated sequential Q4 revenue growth, a lower selling-expense ratio, and manufacturing initiatives expected to improve margins.

Bullish
  • + RISE manufacturing delivered strong year-over-year revenue growth.
  • + PRISM scan-to-purchase conversion more than doubled to 10% after the app update.
  • + LifePack sales grew nearly 3% year to date.
  • + Management anticipated sequential revenue growth in the fourth quarter.
  • + Selling expense as a percentage of revenue declined to 33.2% from 35.8%.
  • + Moving manufacturing closer to customers is expected to improve gross margin, speed to market, and fixed cost optimization.
Bearish
  • − Q3 revenue declined 14.6% year over year and included a 1.1% foreign-currency headwind.
  • − Customers, paid affiliates, and sales leaders all declined year over year.
  • − Q3 gross margin declined to 65% from 70.5% in the prior year.
  • − Adjusted operating margin declined to 3.7% from 5.9% in the prior year.
  • − Full-year revenue guidance calls for a 15% to 13% decline and includes an approximately 1% foreign-currency headwind.
  • − Full-year reported EPS is expected to be a loss of $5.08 to $4.98 per share, reflecting goodwill impairment and a deferred-tax valuation allowance.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 28.4 · fear Equity put/call 0.72
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −36%
below
Price vs 50-day avg −18%
below
RSI (14) 34
neutral
MACD trend Negative
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −23%
trailing
6-month return −33%
trailing
YTD return −61%
this year
Relative strength −27%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $5 › 200d $6 — 200d above 50d
Institutional flow Distributing
-4% holders QoQ · +29 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
9.16% of shares out · ▼ -1.8% MoM · 11.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
159 holders — near 3-yr low, contrarian setup
Squeeze score 65
elevated · 0–100
Fundamentals
Excellent
Revenue growth +49%
Y/Y
Gross margin 32%
contracting
EPS growth +208%
Y/Y
Free cash flow $46.0M
Buyback $137.3M
remaining
Balance sheet $14.4M
net cash
Quant / Vol
risk profile
Very High
Volatility 46%
annualized · 1-yr
Max drawdown −67%
past year
ATR 5.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 4 of last 8
Latest guidance · from the Earnings Call filed Nov 5, 2026
Revenue · full year Lowered $1.26B – $1.29B
Aug 10, 2026 $1.28B – $1.35B changed to Nov 5, 2026 $1.26B – $1.29B
prior FY $1.49B midpoint −14.2% Y/Y
Annual earnings per share · full year Non-GAAP $0.55 – $0.65
Previous outlook earlier release · from the 8-K filed Feb 12, 2026

Still-open targets the latest release did not restate under the same label.

2026 EPS · 2026 $0.80 – $1.20
Prior guidance period ended · from the Earnings Call filed Aug 10, 2026
Revenue · third quarter $310M – $340M
Reported earnings per share · third quarter $0.00 – $0.09
Adjusted earnings per share · third quarter $0.10 – $0.20
Guided vs delivered · last 8 settled
Revenue third quarter
guided $310M – $340M
$311.01M In line
Reported earnings per share third quarter
guided $0.00 – $0.09
$-0.02 Miss −144.4%
Q2 2026 Revenue Q2 2026
guided $330M – $360M
$320.11M Miss −7.2%
Q2 2026 EPS Q2 2026
guided $0.15 – $0.25
$-5.14 Miss −2670.0%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−36% Bearish
Price vs 50-day avg
−18% Bearish
RSI (14)
34 Neutral
MACD trend
Negative Bearish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $5 › 200d $6 — 200d above 50d
Institutional flow Distributing
-4% holders QoQ · +29 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
9.16% of shares out · ▼ -1.8% MoM · 11.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
159 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $4 Now $4 · 0% Range high $12
vs 200-day avg -36% vs 50-day avg -18%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Earnings Per Share (EPS), excluding certain charges non-GAAP $0.1 Q3 2026 —
Operating Margin, excluding certain charges non-GAAP 3.7% Q3 2026 —
Customers - Americas 183,757 Three Months Ended June 30, 2026 filing —
Customers - Europe & Africa 111,332 Three Months Ended June 30, 2026 filing —
Customers - Hong Kong/Taiwan 36,549 Three Months Ended June 30, 2026 filing —
Customers - Japan 100,849 Three Months Ended June 30, 2026 filing —
Customers - South Korea 54,305 Three Months Ended June 30, 2026 filing —
Customers - Southeast Asia/Pacific 69,354 Three Months Ended June 30, 2026 filing —
Paid Affiliates - Americas 27,337 Three months ended June 30 —
Paid Affiliates - Europe & Africa 13,307 Three months ended June 30 —
Paid Affiliates - Hong Kong/Taiwan 9,390 Three months ended June 30 —
Paid Affiliates - Japan 19,018 Three months ended June 30 —
Paid Affiliates - Mainland China 18,736 Three months ended June 30 —
Paid Affiliates - South Korea 14,826 Three months ended June 30 —
Paid Affiliates - Southeast Asia/Pacific 17,677 Three months ended June 30 —
Provision for income taxes, excluding impact of certain charges non-GAAP $9.11M Six months ended June 30 —
Sales Leaders - Americas 5,041 Three months ended June 30 —
Sales Leaders - Mainland China 5,899 Three months ended June 30 —
Sales Leaders - Southeast Asia/Pacific 3,631 Three months ended June 30 —
Total Customers 660,037 Three months ended June 30 —
Total Paid Affiliates 120,291 Three months ended June 30 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Household & Personal Products — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
NUS
Nu Skin Enterprises, Inc.
this stock
$183.52M -60.8% +49.0% — 9.2%
PG
PROCTER & GAMBLE Co
$389.04B +17.1% +3.3% 25.3 1.0%
UL
Unilever PLC
$136.44B -3.1% — — 0.3%
CL
Colgate Palmolive Co
$77.01B +22.6% +1.7% 37.8 2.3%
RBGLY
Reckitt Benckiser Group PLC
$46.56B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
159
% held
73.2%
Net QoQ
-599.0K sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
184
View
Short & Settlement
Short Interest Falling
Shares short
4.5M
Days to cover
11.3d
Change
-80.3K sh
View
Short Volume
Short vol %
74%
As of
Nov 19, 2026
Short Total
View
Fails to Deliver
FTD shares
1.0K
Value
$4.9K
As of
Oct 13, 2026
View
Off-Exchange
Off-exchange %
42.8%
Week of
Oct 12, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$1.5B
Net income (FY)
$160.2M
EPS diluted
$3.18
View
Buybacks
Authorized
$500.0M
Remaining
$137.3M
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 6, 2026
This year
17

Nu Skin reported third-quarter revenue down 14.6% to $311.0 million and a nine-month net loss of $(248.7) million, compared with $145.7 million in the prior-year period.

View
Proposed Sales
Value
$40.5K
Shares
7.2K
Filed
Jun 2, 2026
View
Earnings & Events
Webcasts
Last webcast
Nov 5, 2026
View
Investor Relations
Latest news
Nu Skin Enterprises Reports Third…
Published
Nov 5, 2026
View

Performance

5D 20D 120D MTD YTD
NUS -6.0% -23.4% -33.0% -18.9% -60.8%
SPY -5.5% -6.3% -5.6% -5.3% +5.0%
vs SPY -0.5% -17.1% -27.4% -13.7% -65.8%

Capital returns

Latest dividend
$0.06 / share · ex Aug 28, 2026
Declared · upcoming
$0.06 / share · ex Nov 27, 2026
Cut 84.6%
Paid (TTM)
$0.24 / share · 4 payouts
Dividend yield (TTM, derived)
6.37%
Full dividend history
Buyback program · as of Nov 5, 2026
Authorized
$500.00M
Spent (derived)
$362.70M
Remaining
$137.30M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1021561 CUSIP 67018T105 13F (30d) 179 filings 148 filers Visit website Investor relations